collecting tissue and/or blood samples from every patient who receives
care in the PMCC, we can support our current research programs and build
a repository of specimens to be used for future research. This can lead
the way for discovery of new disease pathways and new treatments. This
is our vision for our new PMCC Cardiovascular Biobank.
The Hearts & Minds 22q Biobank
will be a world leader in research into 22q11.2 Deletion Syndrome,
bringing together a unique facility that combines specimen collection
and storage with annotation of the clinical and molecular phenotype of
all patients with this syndrome.